Prospective, Randomised, Double Blinded Trial Comparing Effectiveness of Platelet Rich Plasma or Placebo in a Primary Meniscal Tear Treatment (Prolotherapy)

NCT03066583 Phase 2/Phase 3 COMPLETED

This study will compare meniscal healing augmented or without augmentation with platelet rich plasma in primary meniscal tear treatment (prolotherapy). The assessments will include validated, disease specific, patient oriented outcome measures. Results of this study will help ascertain whether platelet rich plasma may improve meniscal healing rates.

Details

Lead sponsor	Centre of Postgraduate Medical Education
Phase	Phase 2/Phase 3
Status	COMPLETED
Enrolment	72
Start date	2016-01
Completion	2020-06

Conditions

• Meniscus Lesion

Interventions

• trephination with placebo
• trephination with platelet rich plasma

Primary outcomes

• Assessment of meniscal healing by MR scanning — by 1 year
  The primary outcome measures will be assessment of meniscal healing integrity by MR scanning

Countries

Poland